Outcomes Of Cancer Surgery During COVID-19 Pandemic
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2020/05/025160
- Lead Sponsor
- niversity Of Birmingham United Kingdom
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2970
Inclusion Criteria
1. Any centres performing elective cancer surgery are eligible for participation.
2. Adults (age >=18 years) with a confirmed diagnosis of an included cancer type
3. Multidisciplinary team (tumour board) decision for (or would have been made for) surgical management with a curative intent during the pre-COVID-19 era.
Exclusion Criteria
1. Surgery planned with non-curative intent.
2. Planned neoadjuvant therapy without a firm date for surgery, or awaiting restaging.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 30-day postoperative COVID-19 infection rateTimepoint: 30-day postoperative COVID-19 infection rate
- Secondary Outcome Measures
Name Time Method 1. 30-day postoperative mortality rate. <br/ ><br>2. Postoperative critical care utilisation rate in high-risk cancer surgery patients. <br/ ><br>3. Proportion of patients with delay of greater than 4 weeks from decision for surgery to date <br/ ><br>of surgery. <br/ ><br>4. Proportion of non-operated patients with progression to incurable disease by 3-months after decision for surgery.Timepoint: 30 days postoperatively (with Day 0 as the day of surgery). <br/ ><br>3 months (Outcomes for non-operated patients)